PharVision Advisers’s Banco Macro BMA Stock Holding History

PharVision Advisers’s Portfolio BMA Stock Details BMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,870	Closed	-$259K	–	164
2025 Q4	$259K	Buy	+2,870	New	+$217K	0.13%	372

Other funds holding BMA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TIAM

TT International Asset Management London, United Kingdom $783M AUM 104.75% 1-Year Est. Return

CAAM

Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

PharVision Advisers's BMA Position: Q1 2026 in Review

PharVision Advisers sold out of Banco Macro (BMA) in Q1 2026, closing a stake of 2,870 shares — an estimated $259K sold.

PharVision Advisers first reported a position in BMA in Q4 2025 and held it in 1 quarter. The position peaked at $259K in Q4 2025. 86 funds tracked by Wall St. Rank hold BMA as of Q1 2026.

PharVision Advisers reported no remaining Banco Macro position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 2,870 Banco Macro shares in Q1 2026, an estimated $259K.
PharVision Advisers first reported a position in Banco Macro in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Banco Macro position peaked at $259K in Q4 2025.
86 funds tracked by Wall St. Rank held Banco Macro as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.